Filing Details
- Accession Number:
- 0001144204-11-023485
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-21 17:41:15
- Reporting Period:
- 2011-04-19
- Filing Date:
- 2011-04-21
- Accepted Time:
- 2011-04-21 17:41:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1268659 | Prolor Biotech Inc. | PBTH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403497 | K Adam Stern | 535 Madison Avenue 18Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-04-19 | 479,271 | $5.51 | 127,933 | No | 4 | S | Indirect | Spencer Trask Breakthrough Partners LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Spencer Trask Breakthrough Partners LLC |
Footnotes
- Shares transferred to lender pursuant to lender's foreclosure on a bona fide pledge of such shares by Spencer Trask Breakthrough Partners LLC ("Breakthrough"). Price reported is the closing price of the Common Stock as reported on the NYSE Amex on the date of foreclosure.
- Held by Breakthrough over which Mr. Stern does not have either voting or dispositive power. Mr. Stern disclaims beneficial ownership of the shares of common stock held by Breakthrough except to the extent of his pecuniary interest therein.